Muhammad Yusoff, Farhana <br/><br/>
Th1, Th2, and Th17 cytokines in systemic lupus erythematosus.  [electronic resource] 

 -  Autoimmunity  02 2020 
 - 8-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1607-842X 
<br/><br/><label>Standard No.: </label>10.1080/08916934.2019.1693545  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Autoimmune Diseases--immunology<br/>Autoimmunity<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Cytokines--metabolism<br/>Disease Susceptibility<br/>Humans<br/>Lupus Erythematosus, Systemic--drug therapy<br/>Molecular Targeted Therapy<br/>Th1 Cells--drug effects<br/>Th17 Cells--drug effects<br/>Th2 Cells--drug effects<br/>Treatment Outcome